Accreditation guidance for UK screening labs:
This article was originally published in Clinica
Health Services Accreditation, the UK National Health Service body set up last year after a series of cervical smear errors in which at least eight women died, has issued safety and quality control indicators for cervical cytology services. The standards are to make sure that the government's demand that all cervical screening laboratories have external accreditation by the middle of this year is fulfilled. The standards include definitions of smear inadequacy, rapid rescreening measures and failsafe recall systems. Guidance will also be issued on how each standard can be achieved.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.